Lianming Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lianming Wu has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
Artem Razumov
Skolkovo Institute Of Science And Technology, Center for Artificial Intelligence Technology, 30/1 Bolshoy blvd., 121205 Moscow, Russia
1 shared publication- Bing-Hua Chen
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication Bingyu Xin
Department of Computer Science, Rutgers University, New Brunswick, NJ 08901, USA
1 shared publicationCarles Garcia-Cabrera
ML-Labs SFI Centre for Research Training in Machine Learning, Dublin City University, Glasnevin Dublin 9, Ireland
1 shared publicationChen Qin
Department of Electrical and Electronic Engineering & I-X, Imperial College London, United Kingdom
1 shared publicationCheng Ouyang
Department of Computing, Imperial College London, London SW7 2AZ, UK; Department of Brain Sciences, Imperial College London, London SW7 2AZ, UK
1 shared publication
Latest Publications
- Open Access
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Pericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Open AccessPericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- Top Cited Papers
- 6 February 2025
- Published by Elsevier in Medical Image Analysis
- Vol. 101, 103485
The state-of-the-art in cardiac MRI reconstruction: Results of the CMRxRecon challenge in MICCAI 2023
- 6 February 2025
- Published by Elsevier in Medical Image Analysis
- Vol. 101, 103485
Top Cited PapersThe state-of-the-art in cardiac MRI reconstruction: Results of the CMRxRecon challenge in MICCAI 2023